Duchenne Muscular Dystrophy (DMD) is caused by mutations in the gene coding for dystrophin, which functions to maintain muscle fiber structure and function, preventing it from being damaged by muscle contraction. Presently, there is no definitive treatment for DMD patients. Current therapies focus on prolonging survival and improving quality of life. Definitive treatment will require that functional dystrophin protein is restored in all affected muscle groups. Possible approaches include cell therapy, gene therapy or a combination of the two. We hope that transplantation of a particular type of muscle repair cell will help us to develop new therapeutic approaches to this disease. Muscle stem cells, termed satellite cells, isolated from healthy donors or patients should be able to provide dystrophin and repair muscle damage in DMD patients. For efficient therapy of DMD, satellite cells which maintain the self-renewing ability are necessary. Therefore, in this proposal, (1) we will focus on the study of how cultured satellite cells maintain their self-renewal capacity. In addition, systemic injection of satellite cells is an essential protocol that will provide healthy ells into all affected muscle tissues in DMD patients. Thus, (2) we will attempt to improve systemic delivery methods for satellite cells using a novel homing receptor expression. Furthermore, we need to use cells that are not rejected by a patient's immune system. (3) We are able to generate an unlimited number of satellite cells from induced pluripotent stem cells (iPSCs) derived from the patient's myoblasts. In combination with gene transduction, this concerted approach will help us to make satellite cells that can be transplanted into patients for a definitie cure of DMD.

Public Health Relevance

Duchenne Muscular Dystrophy (DMD) is caused by mutations in a gene called dystrophin, which acts to maintain muscle fiber structure and function, preventing it from being damaged by muscle contraction. Presently, there is no definitive treatment for DMD patients and current therapies focus on prolonging survival and improving quality of life. In combination with gene transduction of a functional dystrophin protein this concerted approach will enable us to make satellite cells that can be transplanted into patients for a definitive cure of DMD.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
4R01AR062142-05
Application #
9116766
Study Section
Skeletal Muscle Biology and Exercise Physiology Study Section (SMEP)
Program Officer
Cheever, Thomas
Project Start
2012-08-01
Project End
2017-07-31
Budget Start
2016-08-01
Budget End
2017-07-31
Support Year
5
Fiscal Year
2016
Total Cost
$339,750
Indirect Cost
$114,750
Name
University of Minnesota Twin Cities
Department
Neurology
Type
Schools of Medicine
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Lowe, Matthew; Lage, Jacob; Paatela, Ellen et al. (2018) Cry2 Is Critical for Circadian Regulation of Myogenic Differentiation by Bclaf1-Mediated mRNA Stabilization of Cyclin D1 and Tmem176b. Cell Rep 22:2118-2132
Verma, Mayank; Asakura, Yoko; Murakonda, Bhavani Sai Rohit et al. (2018) Muscle Satellite Cell Cross-Talk with a Vascular Niche Maintains Quiescence via VEGF and Notch Signaling. Cell Stem Cell 23:530-543.e9
Mademtzoglou, Despoina; Asakura, Yoko; Borok, Matthew J et al. (2018) Cellular localization of the cell cycle inhibitor Cdkn1c controls growth arrest of adult skeletal muscle stem cells. Elife 7:
Mohan, Amrudha; Asakura, Atsushi (2017) CDK inhibitors for muscle stem cell differentiation and self-renewal. J Phys Fit Sports Med 6:65-74
Chowdhury, Neeladri; Asakura, Atsushi (2017) In Utero Stem Cell Transplantation: Potential Therapeutic Application for Muscle Diseases. Stem Cells Int 2017:3027520
Hron, Alexander J; Asakura, Atsushi (2017) An Examination of the Role of Transcriptional and Posttranscriptional Regulation in Rhabdomyosarcoma. Stem Cells Int 2017:2480375
Kodaka, Yusaku; Rabu, Gemachu; Asakura, Atsushi (2017) Skeletal Muscle Cell Induction from Pluripotent Stem Cells. Stem Cells Int 2017:1376151
Kodaka, Yusaku; Asakura, Yoko; Asakura, Atsushi (2017) Spin infection enables efficient gene delivery to muscle stem cells. Biotechniques 63:72-76
Wang, Chao; Liu, Weiyi; Nie, Yaohui et al. (2017) Loss of MyoD Promotes Fate Transdifferentiation of Myoblasts Into Brown Adipocytes. EBioMedicine 16:212-223
Verma, Mayank; Murkonda, Bhavani Sr; Asakura, Yoko et al. (2016) Skeletal Muscle Tissue Clearing for LacZ and Fluorescent Reporters, and Immunofluorescence Staining. Methods Mol Biol 1460:129-40

Showing the most recent 10 out of 22 publications